Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...
In the world of health, Novo Nordisk stops insulin pen production, Trump's potential health appointments draw attention, and ...
In Uganda, especially in rural Uganda and the elderly populace, the diabetes epidemic presents daunting hurdles ...
Thursday is World Diabetes Day. Diabetes affects 40 million Americans and for most, the best form of treatment includes ...
Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.
Say goodbye to ink spills and dead pens, and hello to a future where your pen is always ready to go. It's on sale for a ...
Middleton High School student Will Garlock fulfills his dream by signing with the University of Wisconsin men's basketball ...
A recent study that found there has been a massive increase in type 2 diabetes cases worldwide since 1990 is an indication that the market for GLP-1 drugs could likely be a lot bigger. Based on data ...
Novo Nordisk said Thursday that it plans to eventually halt all of its human insulin pen production globally, ...
Novo Nordisk is ceasing production of human insulin pens, focusing on newer obesity and diabetes injections. This shift has ...
Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback